FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Myopia and Presbyopia Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...

Please provide your email address to receive an email when new articles are posted on . In the United States, two different corneal inlays for the treatment of presbyopia are undergoing U.S. Food and ...

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Myopia And Presbyopia Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...

The MarketWatch News Department was not involved in the creation of this content. The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by ...

TearOptix, Inc., a pioneering contact lens company developing advanced solutions for patients with presbyopia, today announced the completion of a strategic corporate financing round led by investors ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. I’ve said it before: There are four stages of life.

DUBLIN--(BUSINESS WIRE)--The "Global Myopia and Presbyopia Treatment Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The market for myopia and presbyopia treatment is ...